FDA information regarding COVID-19

March 18, 2020

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

Guidance for Industry, Investigators, and Institutional Review Boards

March 27, 2020

FDA Updates Guidance with an Appendix Adding Questions and Answers on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic

Guidance for Industry, Investigators, and Institutional Review Boards

April 7, 2020

Visit the FDA Coronavirus (COVID-19) | Drugs page to learn more about efforts led by The Center for Drug Evaluation and Research (CDER), and for contact information.

April 13, 2020

Visit FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic Guidance for Industry, Investigators, and Institutional Review Boards

April 17, 2020

FDA Updates Question-and-Answer Appendix in Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency